Global Anticoagulant Market
The Global Anticoagulants market was valued at US$ 34.0 billion in 2021 and is anticipated to reach at USD 60.8 billion by 2027 at a CAGR 10.2% from 2022-2027.
Anticoagulant drugs (also called as blood thinner) are chemical substances prevent or reduce blood and increase the blood clotting time. These drugs are chiefly used for high risk of blood clots in various medical conditions such as atrial fibrillation, deep vein thrombosis, myocardial infraction, pulmonary embolism, stroke and others.
Market Drivers
The Global anticoagulant industry is expected to show remarkable growth in the upcoming period due to increasing incidence of venous thromboembolism (VTE) and cardiovascular disorders, increasing adoption of novel oral anticoagulants, and rise in knowledge of NOACs in developing countries. Additionally, rise in number of obese and elderly people, higher unmet needs flow in demand of novel therapeutics promote the market growth. Oral anticoagulants market has observed the steady growth and there is fast expansion in product productions. Over the past decade, more patient-friendly, better compliant dosage form improved demand for oral coagulants market.
Market Restraints
Higher price of NOACs and lack of antidots for NOACs hamper the anticoagulant market. The novel oral anticoagulants are new class of anticoagulant drugs. NOCs have major pharmacologic benefit over warfarin, such as fast onset and offset of action, minimum drug interactions, and predictable pharmacokinetics. Although, these novel drugs have higher price and lead to rise in healthcare costs that may limit their adoption and in turn impede the anticoagulant market growth.
Market segmentation
The Global Anticoagulants market is segmented into Drug Class, route of administration, Application.
By Drug Class such as NOACs (Eliquis, Bevyxxa, Xarelto, Savaysa & lixiana, Pradaxa), Heparin & LMWH, Vitamin K Antagonist, Others. By Route of Administration such as Oral anticoagulant, Injectable anticoagulant. By Application such as Atrial fibrillation & heart attack, Stroke, Deep vein thrombosis (DVT), Pulmonary embolism (PE), Others.
Regional Analysis
The Global Anticoagulants market is segmented into five regions North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America brings about a revenue of USD 10.10 billion in 2018 and is expected to turn up superior in the global market during the forecast period. Asia Pacific is anticipated to witness the highest growth in the market value. Europe is anticipated to witness noteworthy growth in the market due to cardiovascular disease causes more than half of all deaths across the region, that is resulting in the higher adoption of blood thinning medications.
Key Players
Various Key Players are listed in this report such as Boehringer Ingelheim, BMS, Johnson & Johnson, Sanofi, Pfizer Inc., AstraZeneca, Bayer, Cellceutix, Cosmo Pharmaceuticals, CSL Behring.
Market Taxonomy
By Drug Class
By Route of Administration
By Application
By Region
Global Anticoagulant Market TOC
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Anticoagulant Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Anticoagulant Market, By Drug Class
5.1 Y-o-Y Growth Comparison, By Drug Class
5.2 Global Anticoagulant Market Share Analysis, By Drug Class
5.3 Global Anticoagulant Market Size and Forecast, By Drug Class
5.3.1 NOACs
5.3.1.1 Eliquis
5.3.1.2 Bevyxxa
5.3.1.3 Xarelto
5.3.1.4 Savaysa & lixiana
5.3.1.5 Pradaxa
5.3.2 Heparin & LMWH
5.3.4 Vitamin K Antagonist
5.3.5 Others
6 Global Anticoagulant Market, By Route of Administration
6.1 Y-o-Y Growth Comparison, By Route of Administration
6.2 Global Anticoagulant Market Share Analysis, By Route of Administration
6.3 Global Anticoagulant Market Size and Forecast, By Route of Administration
6.3.1 Oral anticoagulant
6.3.2 Injectable anticoagulant.
7 Global Anticoagulant Market, By Application
7.1 Y-o-Y Growth Comparison, By Application
7.2 Global Anticoagulant Market Share Analysis, By Application
7.3 Global Anticoagulant Market Size and Forecast, By Application
7.3.1 Atrial fibrillation & heart attack
7.3.2 Stroke
7.3.3 Deep vein thrombosis (DVT)
7.3.4 Pulmonary embolism (PE)
7.3.5 Others.
8 Global Anticoagulant Market, By Region
8.1 Global Anticoagulant Market Share Analysis, By Region
8.2 Global Anticoagulant Market Share Analysis, By Region
8.3 Global Anticoagulant Market Size and Forecast, By Region
9 North America Immunoassay Market Analysis and Forecast (2022-2027)
9.1 Introduction
9.2 North America Immunoassay Market Share Analysis, By Drug Class
9.3 North America Immunoassay Market Size and Forecast, By Route of Administration
9.4 North America Immunoassay Market Size and Forecast, By Application
9.5 North America Immunoassay Market Size and Forecast, By Country
9.5.1 U.S.
9.5.2 Canada
9.5.3 Mexico
10 Europe Immunoassay Market Analysis and Forecast (2022-2027)
10.1 Introduction
10.2 Europe Immunoassay Market Share Analysis, By Drug Class
10.3 Europe Immunoassay Market Size and Forecast, By Route of Administration
10.4 Europe Immunoassay Market Size and Forecast, By Application
10.5 Europe Immunoassay Market Size and Forecast, By Country
10.5.1 Germany
10.5.2 France
10.5.3 UK
10.5.4. Rest of Europe
11 Asia Pacific Immunoassay Market Analysis and Forecast (2022-2027)
11.1 Introduction
11.2 Asia Pacific Immunoassay Market Share Analysis, By Drug Class
11.3 Asia Pacific Immunoassay Market Size and Forecast, By Route of Administration
11.4 Asia Pacific Immunoassay Market Size and Forecast, By Application
11.5 Asia Pacific Immunoassay Market Size and Forecast, By Country
11.5.1 China
11.5.2 Japan
11.5.3 India
11.5.4. Rest of Asia Pacific
12 Latin America Immunoassay Market Analysis and Forecast (2022-2027)
12.1 Introduction
12.2 Latin America Immunoassay Market Share Analysis, By Drug Class
12.3 Latin America Immunoassay Market Size and Forecast, By Route of Application
12.4 Latin America Immunoassay Market Size and Forecast, By Application
12.5 Latin America Immunoassay Market Size and Forecast, Country
12.5.1. Brazil
12.5.2. Rest of Latin America
13 Middle East Immunoassay Market Analysis and Forecast (2022-2027)
13.1 Introduction
13.2 Middle East Immunoassay Market Share Analysis, By Drug Class
13.3 Middle East Immunoassay Market Size and Forecast, By Route of Administration
13.4 Middle East Immunoassay Market Size and Forecast, By Application
13.5 Middle East Immunoassay Market Size and Forecast, By Country
13.5.1. Saudi Arabia
13.5.2. UAE
13.5.3. Egypt
13.5.4. Kuwait
13.5.5. South Africa
14 Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15 Company Profiles
15.1 Boehringer Ingelheim
15.1.1 Overview
15.1.2 Products
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2 BMS
15.2.1 Overview
15.2.2 Products
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3 Johnson & Johnson
15.3.1 Overview
15.3.2 Products
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 Sanofi
15.4.1 Overview
15.4.2 Products
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 Pfizer Inc
15.5.1 Overview
15.5.2 Products
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 AstraZeneca
15.6.1 Overview
15.6.2 Products
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 Bayer
15.7.1 Overview
15.7.2 Products
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 Cellceutix
15.8.1 Overview
15.8.2 Products
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 Cosmo Pharmaceuticals
15.9.1 Overview
15.9.2 Products
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies
15.10 CSL Behring
15.10.1 Overview
15.10.2 Products
15.10.3 Key Financials
15.10.4 Business Segment & Geographic Overview
15.10.5 Key Market Developments
15.10.6 Key Strategies
